It has been reported that IGLL5 may act as a risk factor and was related with metastasis and poor prognosis of multiple myeloma (White et al., 2018; Barwick et al., 2019; D'Agostino et al., 2020). The gene discussed is IGLL5; the disease is plasma cell myeloma.